Exhibit 99.1
JOINT FILING AGREEMENT
The undersigned agree that the statement on Schedule 13D, dated December 5, 2014, with respect to the Common Stock of Cocrystal Pharma, Inc. is, and any amendments hereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13(d) under the Securities Exchange Act of 1934, as amended.
December 5, 2014 | /s/ Raymond F. Schinazi | |
Date | Raymond F. Schinazi | |
December 5, 2014 | /s/ Phillip Frost, M.D. | |
Date | Phillip Frost, M.D. | |
December 5, 2014 | Frost Gamma Investments Trust By: /s/ Phillip Frost, M.D. | |
Date | Phillip Frost, M.D., Trustee | |
December 5, 2014 | OPKO Health, Inc. By: /s/ Phillip Frost, M.D. | |
Date | Phillip Frost, M.D., Chief Executive Officer | |
December 5, 2014 | Bracrystal Pharmaceuticals, LLC By: /s/ Vinzenz Ploerer | |
Date | Vinzenz Ploerer, President and Chief Executive Officer | |
December 5, 2014 | /s/ Gary Wilcox | |
Date | Gary Wilcox | |
December 5, 2014 | /s/ Roger Kornberg | |
Date | Roger Kornberg | |
December 5, 2014 | /s/ Sam Lee | |
Date | Sam Lee | |
December 5, 2014 | /s/ Steven D. Rubin | |
Date | Steven Rubin |